| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Silent Strokes Linked to Kidney Failure in Patients With Diabetes WASHINGTON, DC -- January 28, 2010 -- In patients with type 2 diabetes, silent cerebral infarction (SCI) signals an increased risk of progressive kidney disease and kidney failure, according to a study published early online and appearing in an upcoming issue of the Journal of the American Society Nephrology. The results of the study suggest that if SCI is present in the brain, it could be an indicator that small-vessel damage is present in the kidneys as well. “Silent cerebral infarction may be a new marker to identify patients who are risk for declining kidney function,” Takashi Uzu, MD, Shiga University School of Medicine, Otsu, Japan. The study included 608 patients with type 2 diabetes, all initially free of symptomatic stroke, heart disease, or kidney disease (overt proteinuria or renal dysfunction). On magnetic resonance imaging (MRI) scans of the brain, 177 of the patients (29%) had SCI, but not severe enough to cause overt symptoms of stroke. At long-term follow-up, diabetic patients with SCI had higher risks of progressive kidney disease. Compared with those with normal brain MRI scans, patients with SCI were about 2.5 times more likely to die or develop end-stage kidney disease. Their risk of declining kidney function or dialysis was nearly 5 times higher. New approaches are needed to assess the risk of diabetes-related kidney disease. The study shows that patients with diabetes with subtle brain damage detected on MRI scans are more likely to develop serious kidney disease, independent of “Evaluating both SCI and microalbuminuria may be useful for determining the risk of progression of kidney disease in diabetic patients,” said Dr. Uzu. The study had some risk of bias related to patient selection. Also, although most of the patients with SCI had multiple small areas of brain damage, the study did not exclude patients with relatively large areas of brain damage. “Therefore, not only small vessel disease but also relatively large vessel disease might have affected the progression of kidney disease in our patients,” added Dr. Uzu.
SOURCE: American Society of Nephrology
|